Showing results (711-720 of 893) with videos related to

Sort By:
Pageof 90
Cardiovascular Diabetology|July 18, 2024
Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) RegistryArthur Shiyovich, Adam N Berman, Stephanie A Besser, et al.
JACC. Heart Failure|September 16, 2023
Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF: Post-Hoc Analysis of EMPEROR-ReducedNitish K Dhingra, Subodh Verma, Javed Butler, et al.
Journal of Cardiac Failure|August 9, 2023
Vascular Disease Burden, Outcomes and Benefits with Empagliflozin in Heart Failure: Insights From the EMPEROR-Reduced TrialMuhammad Shahzeb Khan, Stefan D Anker, Gerasimos Filippatos, et al.
Toxicology and Applied Pharmacology|May 27, 2018
Effects of acute and chronic methamphetamine administration on cynomolgus monkey hippocampus structure and cellular transcriptomeMi Ran Choi, Ji-Won Chun, Su Min Kwak, et al.
Scientific Reports|December 17, 2022
Machine learning-derived gut microbiome signature predicts fatty liver disease in the presence of insulin resistanceBaeki E Kang, Aron Park, Hyekyung Yang, et al.
Epidemiology and Psychiatric Sciences|July 16, 2020
Bidirectional association between blood pressure and depressive symptoms in young and middle-age adults: A cohort studySang Won Jeon, Yoosoo Chang, Se-Won Lim, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 13, 2023
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysisGerasimos Filippatos, Stefan D Anker, Phyllis August, et al.
JACC. Clinical Electrophysiology|August 11, 2023
Impact of SGLT2 Inhibitors on AF Recurrence After Catheter Ablation in Patients With Type 2 DiabetesMoh'd Rasheed Abu-Qaoud, Ashish Kumar, Tushar Tarun, et al.
Pageof 90